Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Michelle A. Uberti"'
Autor:
Dario Doller, Guiying Li, Hermogenes N. Jimenez, Robbin Brodbeck, Michelle A. Uberti, Daniel G. Smith, Hao Zhou, Jens Christian Madsen, Henrik Pedersen, Michel Grenon, Gamini Chandrasena, Sidney W. Topiol
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 23:1398-1406
A novel series of trans-1,3-cyclohexyl diamides was discovered and characterized as mGluR5 negative allosteric modulators (NAMs) lacking an alkyne moiety. Conformational constraint of one of the amide bonds in the diamide template led to a spirooxazo
Autor:
Manuel Cajina, Megan Nattini, Michael Sabio, Michael S. Reitman, Dario Doller, Kevin G. Liu, Maria D. Bacolod, Hermogenes N. Jimenez, Sang-Phyo Hong, Michelle A. Uberti
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 22:3235-3239
4-(1-Phenyl-1H-pyrazol-4-yl)quinoline (1) was identified by screening the Lundbeck compound collection, and characterized as having mGlu4 receptor positive allosteric modulator properties. Compound 1 is selective over other mGlu receptors and a panel
Autor:
Søren Møller Nielsen, Hans Bräuner-Osborne, Ulf Madsen, Trine Kvist, Birgitte H. Kaae, Birgitte Nielsen, Hermogenes N. Jimenez, Kasper Harpsøe, Rasmus P. Clausen, Christina Mølck, Michelle A. Uberti, David E. Gloriam, Jesper Mosolff Mathiesen, Per Sauerberg
Publikováno v:
ChemMedChem. 7:440-451
A series of compounds based on the mGluR5-selective ligand 2-methyl-6-(phenylethynyl)pyridine (MPEP) were designed and synthesized. The compounds were found to be either structural analogues of MPEP, substituted monomers, or dimeric analogues. All co
Autor:
Poda Suresh Babu, Michelle A. Uberti, Arun Ranganathn, Michael Sabio, Claus T. Christoffersen, Veena Menon, Vincent H. Jorgensen, Kenneth A. Jones
Publikováno v:
ASSAY and Drug Development Technologies. 6:787-794
A luminescence assay using a new plate reader, the LumiLux (PerkinElmer, Waltham, MA), has been validated for high-throughput screening (HTS). In this study, we compared the aequorin luminescence-based calcium mobilization assay to the fluorescence-b
Autor:
Cristina F. Bush, Randy A. Hall, Kerry J. Ressler, Seth V. Jones, Chris Hague, Kenneth P. Minneman, Michelle A. Uberti, Zhongjian Chen
Publikováno v:
Proceedings of the National Academy of Sciences. 101:13672-13676
Olfactory receptors (ORs) comprise more than half of the large class I G protein-coupled receptor (GPCR) superfamily. Although cloned over a decade ago, little is known about their properties because wild-type ORs do not efficiently reach the cell su
Publikováno v:
Journal of Biological Chemistry. 279:15541-15549
alpha(1)-Adrenergic receptors (ARs) belong to the large Class I G protein-coupled receptor superfamily and comprise three subtypes (alpha(1A), alpha(1B), and alpha(1D)). Previous work with heterologously expressed C-terminal green fluorescent protein
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1645:193-204
The formation of coenzyme A thioesters from long-chain fatty acids represents a metabolic branch point. We have isolated, cloned and sequenced a long-chain fatty acyl CoA synthetase (LCFACoAS) that is localized to the endothelium of rabbit heart and
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 302:58-65
Human alpha(1A)-, alpha(1B)-, and alpha(1D)-adrenergic receptors were tagged at their amino termini with FLAG epitopes and stably expressed in human embryonic kidney (HEK)293 cells. Tagged receptors demonstrated a wild-type pharmacology and mobilizat
Autor:
Michelle A. Uberti, Agnieszka Pałucha-Poniewiera, Katarzyna Stachowicz, Dario Doller, Maria A. Bacolod, Joanna M. Wierońska, Andrzej Pilc, Anna Sławińska
Previous studies demonstrated that the Group III mGlu receptor-selective orthosteric agonist, LSP1-2111 produced anxiolytic- but not antidepressant-like effects upon peripheral administration. Herein, we report the pharmacological actions of Lu AF219
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e3f22faaea2cc80e718056d9be38414
https://ruj.uj.edu.pl/xmlui/handle/item/97567
https://ruj.uj.edu.pl/xmlui/handle/item/97567
Autor:
Lydia Kerkerian-Le Goff, Dario Doller, Christophe Melon, Khaled-Ezaheir Bennouar, Maria D. Bacolod, Hermogenes N. Jimenez, Paolo Gubellini, Manuel Cajina, Michelle A. Uberti
Publikováno v:
Neuropharmacology
Neuropharmacology, 2013, 66, pp.158-69. ⟨10.1016/j.neuropharm.2012.03.022⟩
Neuropharmacology, Elsevier, 2013, 66, pp.158-69. ⟨10.1016/j.neuropharm.2012.03.022⟩
Neuropharmacology, 2013, 66, pp.158-69. ⟨10.1016/j.neuropharm.2012.03.022⟩
Neuropharmacology, Elsevier, 2013, 66, pp.158-69. ⟨10.1016/j.neuropharm.2012.03.022⟩
Group III metabotropic glutamate (mGlu) receptors are localized in presynaptic terminals within basal ganglia (BG) circuitry that become hyperactive due to dopamine depletion in Parkinson's disease (PD). For this reason, group III mGlu receptors, in